This webinar took place on Monday 18th May 2020 and is available for healthcare professionals to watch below
This webinar was supported by Vifor Pharma UK with an unrestricted educational grant
Ms Carys Barton, Heart Failure Nurse Consultant, Imperial College Healthcare Trust, London |
|
Professor Paul Kalra, Consultant Cardiologist, Portsmouth Hospitals NHS Trust |
|
Professor Philip Kalra, Consultant Nephrologist, Salford Royal NHS Foundation Trust |
Professor John McMurray, Professor of Cardiology, University of Glasgow |
|
Dr Geraint Morton, Consultant Cardiologist, Portsmouth Hospitals NHS Trust |
Webinar moderator: Professor Paul Kalra, Consultant Cardiologist, Portsmouth Hospitals NHS Trust and University of Portsmouth | |
18.00 | Renin-angiotensin-aldosterone system blockers, SGLT2 inhibitors and COVID-19. Should we be concerned? Professor John McMurray, Professor of Cardiology, University of Glasgow
|
18.15 | The renal patient – priorities and practicalities in delivering care Professor Philip Kalra, Consultant Nephrologist, Salford Royal NHS Foundation Trust; Professor of Renal Medicine, University of Manchester
|
18.30 | Managing heart failure in COVID-times: troubles, tips and triumphs Ms Carys Barton, Heart Failure Nurse Consultant, Imperial College Healthcare Trust, London, and Dr Geraint Morton, Consultant Cardiologist, Portsmouth Hospitals NHS Trust
|
18.45 | Q&A session Your questions answered by the webinar panel Moderated by Professor Paul Kalra |
The Cardiorenal Forum has organised the programme and selected the speakers.
Would you like us to send you regular updates about the activities of the Cardiorenal Forum, including meetings?
98%of delegates said the 2019 meeting |
98%of delegates found the 2019 programme |
100%of delegates said the 2019 meeting organisation |